Novadaq Technologies Inc. (TSE:NDQ)‘s stock had its “outperform” rating restated by analysts at Wedbush in a research note issued on Tuesday. They currently have a C$17.00 price objective on the stock.

Separately, Royal Bank Of Canada reissued an “outperform” rating on shares of Novadaq Technologies in a report on Thursday, July 7th.

Shares of Novadaq Technologies (TSE:NDQ) traded up 2.27% on Tuesday, reaching $15.80. 605 shares of the company’s stock were exchanged. The company’s 50 day moving average price is $15.11 and its 200-day moving average price is $13.75. The stock’s market cap is $907.47 million. Novadaq Technologies has a 52-week low of $10.81 and a 52-week high of $20.40.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Novadaq Technologies Company Profile

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with's FREE daily email newsletter.